Loratadine Combix 10 mg tablets EFG

Spain
Brand name Loratadine Combix 10 mg tablets EFG
Form tablets
Active substance / Dosage
LORATADINE · 10 mg
Prescription type Prescription Only Medicine
Registration number 75118
Loratadine Combix 10 mg tablets EFG tablets

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Loratadine Combix 10 mg tablets EFG

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor, pharmacist or nurse.
  • This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, since it could harm them.
  • If you experience any adverse effects, consult your doctor, pharmacist or nurse, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

  1. What Loratadine Combix is and what it is used for
  2. What you need to know before taking Loratadine Combix
  3. How to take Loratadine Combix
  4. Possible adverse effects
  5. How to store Loratadine Combix
  6. Contents of the pack and other information

1. What Loratadina Combix is and what it is used for

Loratadina Combix belongs to a class of medicines known as antihistamines.

Loratadina Combix relieves symptoms associated with allergic rhinitis (such as sneezing, runny or itchy nose, and burning or itchy eyes).

Loratadina Combix may also be used to help relieve symptoms of urticaria (such as itching, redness, and the number and size of skin rashes).

2. What you need to know before taking Loratadine

Do not take Loratadine Combix

  • If you are allergic (hypersensitive) to the active substance loratadine or to any of the other components of this medicine.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting to take Loratadine Combix:

  • if you have severe liver disease (see section 3. How to take Loratadine Combix).
  • if you are due to undergo any type of skin allergy testing. Do not take Loratadine Combix during the 2 days prior to such tests, as this medicine may alter the test results.

Interaction of Loratadine Combix with other medicines

Inform your doctor or pharmacist if you are taking, or have recently taken any other medicines, including those obtained without a prescription.

No interactions between Loratadine Combix and other medicines are known. Nevertheless, inform your doctor or pharmacist if you are using or have recently used other medicines.

Loratadine Combix with food, drink and alcohol

Loratadine Combix may be taken with or without food.

Pregnancy, breastfeeding and fertility

Consult your doctor or pharmacist before taking any medicine.

Loratadine Combix is not recommended if you are pregnant or breastfeeding.

Driving and using machines

At normal doses, Loratadine Combix does not affect the ability to drive or operate machinery. If you experience symptoms of drowsiness, do not drive or use machinery. However, avoid performing tasks that may require special attention until you know how you tolerate the medicine.

Important information about some of the components of Loratadine Combix

This medicine contains lactose. If your doctor has informed you that you have an intolerance to certain sugars, consult with him before taking this medicine.

3. How to take Loratadina Combix

Follow the administration instructions for Loratadina Combix as indicated by your doctor.

Remember to take your medication. Consult your doctor or pharmacist if you have any doubts.

Your doctor will determine the duration of treatment with Loratadina Combix. Do not stop treatment prematurely.

Adults and children over 2 years of age weighing more than 30 kg

Take one tablet (10 mg) once daily.

Patients with severe liver problems weighing more than 30 kg

Take one tablet (10 mg) once daily, on alternate days.

Loratadina Combix is not suitable for:

  • administration of doses lower than 10 mg.
  • administration in patients weighing less than 30 kg.
  • patients who have difficulty swallowing.

Use in children and adolescents

Loratadina Combix is not recommended for children under 2 years of age.

If you take more Loratadina Combix than you should

If you take more Loratadina Combix than you should, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, contact the Toxicology Information Service; Telephone 91562 04 20, indicating the medication and the amount ingested.

If you forget to take Loratadina Combix

If you forget to take your dose on time, take it as soon as possible, then return to your usual dosing schedule. Do not take a double dose to make up for missed doses.

If you stop treatment with Loratadina Combix

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible adverse effects

Like all medicines, Loratadina Combix may cause adverse effects, although not everyone experiences them.

The most frequently reported adverse effects (less than 1 in 10 patients but more than 1 in 100 patients) include drowsiness, headache, nervousness, fatigue, increased appetite, and difficulty sleeping.

Very rarely reported adverse effects (less than 1 in 10,000 patients) have included cases of severe allergic reaction, dizziness, irregular or rapid heartbeat, nausea (feeling sick), dry mouth, stomach pain or acidity, liver problems, hair loss, skin rash, and tiredness.

An adverse effect with frequency "not known" is weight gain.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly through the Spanish Pharmacovigilance System for Human Medicinal Products: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Loratadine Combix

Keep this medicine out of sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month indicated.

No special storage conditions are required.

Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to properly dispose of unused containers and medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Loratadina Combix

The active substance is Loratadine. Each Loratadina Combix tablet contains 10 mg of loratadine.

The other components are monohydrate lactose, corn starch, and magnesium stearate.

Appearance of the product and contents of the pack

Loratadina Combix tablets are white, round, flat tablets, with a score on one side and smooth on the other.

The tablet can be divided into equal halves.

Loratadina Combix is available in packs containing 2, 5, 7, 10, 14, 15, 20, 21, 28, 30, 50 or 100 tablets.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Laboratorios Combix, S.L.U.

C/ Badajoz 2. Edificio 2

28223 Pozuelo de Alarcón (Madrid)

Manufacturer

Zydus France

25, parc d’activités des Peupliers, Bâtiment L

92000 Nanterre

France

or

Centre Specialites Pharmaceutiques

ZAC du Suzot

35 rue de la Chapelle

63450 St Amant Tallende

France

The most recent revision of this leaflet was in January 2018

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/